Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer.Founded by the team that founded and sold Emergence Therapeutics to Eli Lilly and Company.Seed round led by Pontifax and includes top-tier life science investors. Marseille, France, 11 June 2024: Adcytherix SAS today announced its incorporation and seed funding […]